Performance of Single Chamber Microbial Fuel Cell (SCMFC) for biological treatment of tofu wastewater

The wastewater of tofu industries consists of organic compounds and in turn, may affect the environment; therefore, a proper wastewater treatment system is needed. Based on its characteristics, biological treatment is a good method to treat tofu wastewater. One of the biological treatment methods that can be used is Microbial Fuel Cell (MFC), which can reduce the pollutant and at the same time generating low-power electricity. This system utilizes microorganisms as a biocatalyst to degrade organic compounds in the wastewater. This study aimed to examine the performance of Single Chamber MFC (SCMFC) to decrease biochemical oxygen demand (BOD5) and chemical oxygen demand (COD) of the tofu wastewater, as well as to generate electricity. Tofu wastewater was sterilized then filled into the reactor. Microbes that either have been acclimatized or not acclimatized were then added. Bacteria that were used were one of the three consortiums of native microbes of tofu wastewater, namely Escherichia coli, Saccharomycopsis fibuligera, and mixed culture of E. coli and S. fibuligera. Carbon (C) was used as both anode and cathode. We found that the acclimatized mixed culture of E. coli and S. fibuligera showed high BOD5, COD removal after 48 hours at 76.57 and 77.22 %, respectively. It also generated 5.49 mA of current, 757 mV of voltage, and the electrical energy produced was 9.216 x10− 5 kWh. The results suggest that using mixed microorganisms is one of the strategies to improve the electricity generation of MFC. The scale-up of the volume, selection of microorganism cultures, and immobilization could be other strategies for further studies.

Atrovirinone inhibits pro-inflammatory mediator release from murine macrophages and human whole blood

Many plant-derived natural compounds have been reported previously to inhibit the production of important pro-inflammatory mediators such as nitric oxide, prostaglandin E2, TNF-alpha and reactive oxygen species by suppressing inducible enzyme expression via inhibition of the mitogen-activated protein kinase pathway and nuclear translocation of critical transcription factors. This study evaluates the effects of atrovirinone [2-(1-methoxycarbonyl-4,6-dihydroxyphenoxy)-3-methoxy-5,6-di-(3-methyl-2-butenyl)-1,4-benzoquinone)], a benzoquinone that we have previously isolated from Garcinia atroviridis, on two cellular systems that are repeatedly used in the analysis of anti-inflammatory bioactive compounds, namely, RAW 264.7 macrophage cells and whole blood. Atrovirinone inhibited the production of both nitric oxide and prostaglandin E2 from LPS-induced and IFN-gamma-induced RAW 264.7 cells and whole blood, with inhibitory concentration (IC)50 values of 4.62 +/- 0.65 and 9.33 +/- 1.47 micromol/L, respectively. Analysis of thromboxane B2 (TXB2) secretion from whole blood stimulated by either the cyclooxygenase (COX)-1 or the COX-2 pathway showed that atrovirinone inhibits the generation of TXB2 by both pathways, with IC50 values of 7.41 +/- 0.92 and 2.10 +/- 0.48 micromol/L, respectively. Analysis of IC50 ratios showed that atrovirinone was more COX-2 selective in its inhibition of TXB2, with a ratio of 0.32. Atrovirinone also inhibited the generation of intracellular reactive oxygen species and the secretion of TNF-alpha from RAW 264.7 cells in a dose-responsive manner, with IC50 values of 5.99 +/- 0.62 and 11.56 +/- 0.04 micromol/L, respectively. Lipoxygenase activity was also moderately inhibited by atrovirinone. Our results suggest that atrovirinone acts on important pro-inflammatory mediators possibly by the inhibition of the nuclear factor-kappaB pathway and also by the inhibition of the COX/lipoxygenase enzyme activity.

Isolation and bioactivities of constitutents of the roots of Garcinia atroviridis

Two new prenylated compounds, the benzoquinone atrovirinone (1) and the depsidone atrovirisidone (2), were isolated from the roots of Garcinia atroviridis. Their structures were determined on the basis of the analysis of spectroscopic data. While compound 2 showed some cytotoxicity against HeLa cells, both compounds 1 and 2 were only mildly inhibitory toward Bacillus cereus and Staphylococcus aureus.

Anthraquinones from hedyotis herbacea

A new anthraquinone, 2-hydroxymethyl-10-hydroxy-1,4-anthraquinone (1), was isolated from Hedyotis herbacea along with three other known derivatives: 1,4-dihydroxy-2-hydroxymethylanthraquinone (2); 2, 3-dimethoxy-9-hydroxy-1,4-anthraquinone; and 1,4-dihydroxy-2, 3-dimethoxyanthraquinone. The structure of 1 was determined based on analysis of its spectroscopic data.